| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.01e-05 | 23 | 37 | 3 | GO:0046965 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.44e-04 | 55 | 37 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.43e-04 | 582 | 37 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 9.75e-04 | 417 | 37 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 1.81e-03 | 34 | 37 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.20e-03 | 739 | 37 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.41e-03 | 753 | 37 | 6 | GO:0008134 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.53e-03 | 147 | 37 | 3 | GO:0042826 | |
| GeneOntologyBiologicalProcess | diencephalon development | 2.23e-05 | 90 | 38 | 4 | GO:0021536 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 6.05e-05 | 116 | 38 | 4 | GO:0008344 | |
| GeneOntologyBiologicalProcess | cellular response to magnesium ion | 9.19e-05 | 8 | 38 | 2 | GO:0071286 | |
| GeneOntologyBiologicalProcess | cell maturation | 1.24e-04 | 267 | 38 | 5 | GO:0048469 | |
| GeneOntologyBiologicalProcess | brain development | 1.41e-04 | 859 | 38 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 1.65e-04 | 284 | 38 | 5 | GO:0007626 | |
| GeneOntologyBiologicalProcess | protein localization to axon | 1.80e-04 | 11 | 38 | 2 | GO:0099612 | |
| GeneOntologyBiologicalProcess | head development | 2.24e-04 | 919 | 38 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 2.34e-04 | 306 | 38 | 5 | GO:0048863 | |
| GeneOntologyBiologicalProcess | forebrain development | 2.50e-04 | 489 | 38 | 6 | GO:0030900 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.51e-04 | 1194 | 38 | 9 | GO:0000902 | |
| GeneOntologyBiologicalProcess | hemopoiesis | 3.00e-04 | 1223 | 38 | 9 | GO:0030097 | |
| GeneOntologyBiologicalProcess | neuron maturation | 3.42e-04 | 74 | 38 | 3 | GO:0042551 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.79e-04 | 748 | 38 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | thalamus development | 3.90e-04 | 16 | 38 | 2 | GO:0021794 | |
| GeneOntologyBiologicalProcess | neuronal ion channel clustering | 4.42e-04 | 17 | 38 | 2 | GO:0045161 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 4.56e-04 | 354 | 38 | 5 | GO:0071695 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 4.62e-04 | 197 | 38 | 4 | GO:0002244 | |
| GeneOntologyBiologicalProcess | adult behavior | 5.17e-04 | 203 | 38 | 4 | GO:0030534 | |
| GeneOntologyCellularComponent | node of Ranvier | 6.18e-06 | 20 | 38 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | chromatin | NR4A2 SETD1A NCOR1 HES1 SINHCAF CHD7 RUNX2 ZC3H6 EBF3 PPP4R2 | 2.32e-04 | 1480 | 38 | 10 | GO:0000785 |
| GeneOntologyCellularComponent | paranode region of axon | 4.30e-04 | 17 | 38 | 2 | GO:0033270 | |
| GeneOntologyCellularComponent | main axon | 5.65e-04 | 89 | 38 | 3 | GO:0044304 | |
| Domain | SH3_1 | 4.48e-03 | 164 | 38 | 3 | PF00018 | |
| Domain | SANT | 4.64e-03 | 50 | 38 | 2 | SM00717 | |
| Domain | SANT/Myb | 5.01e-03 | 52 | 38 | 2 | IPR001005 | |
| Domain | SH3 | 9.55e-03 | 216 | 38 | 3 | PS50002 | |
| Domain | SH3 | 9.55e-03 | 216 | 38 | 3 | SM00326 | |
| Domain | SH3_domain | 1.00e-02 | 220 | 38 | 3 | IPR001452 | |
| Domain | RRM | 1.13e-02 | 230 | 38 | 3 | PS50102 | |
| Pathway | REACTOME_NRCAM_INTERACTIONS | 9.76e-05 | 7 | 31 | 2 | M27378 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.56e-04 | 48 | 31 | 3 | M288 | |
| Pubmed | 7.76e-08 | 963 | 39 | 10 | 28671696 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 8.94e-07 | 475 | 39 | 7 | 31040226 | |
| Pubmed | Identification of putative target genes of the transcription factor RUNX2. | 1.23e-06 | 2 | 39 | 2 | 24349465 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 2.41e-06 | 1082 | 39 | 9 | 38697112 | |
| Pubmed | HDAC3 is a critical negative regulator of long-term memory formation. | 7.34e-06 | 4 | 39 | 2 | 21228185 | |
| Pubmed | HES1 cooperates with pRb to activate RUNX2-dependent transcription. | 7.34e-06 | 4 | 39 | 2 | 16753023 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 16195230 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 7.39e-06 | 1242 | 39 | 9 | 30973865 | |
| Pubmed | 7.79e-06 | 660 | 39 | 7 | 32780723 | ||
| Pubmed | 1.03e-05 | 689 | 39 | 7 | 36543142 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 29346753 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 20628571 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 11438536 | ||
| Pubmed | 1.25e-05 | 40 | 39 | 3 | 26297811 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.58e-05 | 283 | 39 | 5 | 30585729 | |
| Pubmed | 2.56e-05 | 1103 | 39 | 8 | 34189442 | ||
| Pubmed | HERP, a novel heterodimer partner of HES/E(spl) in Notch signaling. | 2.56e-05 | 7 | 39 | 2 | 11486045 | |
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 21300983 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.76e-05 | 536 | 39 | 6 | 15840001 | |
| Pubmed | 2.82e-05 | 538 | 39 | 6 | 10512203 | ||
| Pubmed | 3.16e-05 | 549 | 39 | 6 | 38280479 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 7750641 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 3.59e-05 | 336 | 39 | 5 | 31253590 | |
| Pubmed | PABP1 identified as an arginine methyltransferase substrate using high-density protein arrays. | 4.39e-05 | 9 | 39 | 2 | 11850402 | |
| Pubmed | Apical expansion of calvarial osteoblasts and suture patency is dependent on fibronectin cues. | 4.39e-05 | 9 | 39 | 2 | 38602508 | |
| Pubmed | 4.39e-05 | 9 | 39 | 2 | 24684754 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 4.41e-05 | 583 | 39 | 6 | 29844126 | |
| Pubmed | Iron deficiency alters expression of genes implicated in Alzheimer disease pathogenesis. | 5.48e-05 | 10 | 39 | 2 | 18723004 | |
| Pubmed | Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. | 5.48e-05 | 10 | 39 | 2 | 15536134 | |
| Pubmed | 6.24e-05 | 191 | 39 | 4 | 20195357 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 31634536 | ||
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 8.03e-05 | 12 | 39 | 2 | 16701205 | |
| Pubmed | Transient and lineage-restricted requirement of Ebf3 for sternum ossification. | 8.03e-05 | 12 | 39 | 2 | 32398354 | |
| Pubmed | Control of the migratory pathway of facial branchiomotor neurones. | 9.48e-05 | 13 | 39 | 2 | 11076752 | |
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 9.48e-05 | 13 | 39 | 2 | 17765891 | |
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 33773996 | ||
| Pubmed | 9.48e-05 | 13 | 39 | 2 | 22421355 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.09e-04 | 82 | 39 | 3 | 31073041 | |
| Pubmed | NOVA2-mediated RNA regulation is required for axonal pathfinding during development. | 1.11e-04 | 14 | 39 | 2 | 27223325 | |
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 31749685 | ||
| Pubmed | DSCAM promotes axon fasciculation and growth in the developing optic pathway. | 1.11e-04 | 14 | 39 | 2 | 28137836 | |
| Pubmed | 1.18e-04 | 1371 | 39 | 8 | 36244648 | ||
| Pubmed | Satb2 is required for the regionalization of retrosplenial cortex. | 1.27e-04 | 15 | 39 | 2 | 31666685 | |
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 29567677 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 25762221 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 38018454 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 19855134 | ||
| Pubmed | 1.46e-04 | 16 | 39 | 2 | 10932191 | ||
| Pubmed | 1.46e-04 | 16 | 39 | 2 | 31823782 | ||
| Pubmed | 1.59e-04 | 1431 | 39 | 8 | 37142655 | ||
| Pubmed | 1.60e-04 | 244 | 39 | 4 | 29884807 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.61e-04 | 462 | 39 | 5 | 31138677 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 26102480 | ||
| Pubmed | Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality. | 1.65e-04 | 17 | 39 | 2 | 24441682 | |
| Pubmed | 1.67e-04 | 1442 | 39 | 8 | 35575683 | ||
| Pubmed | 1.80e-04 | 1084 | 39 | 7 | 11544199 | ||
| Pubmed | Fibronectin isoforms promote postnatal skeletal development. | 1.85e-04 | 18 | 39 | 2 | 39159790 | |
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 26674342 | ||
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 12921743 | ||
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 15689374 | ||
| Pubmed | 1.85e-04 | 18 | 39 | 2 | 31412026 | ||
| Pubmed | 2.07e-04 | 488 | 39 | 5 | 31324722 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.08e-04 | 774 | 39 | 6 | 15302935 | |
| Pubmed | 2.12e-04 | 777 | 39 | 6 | 35844135 | ||
| Pubmed | 2.20e-04 | 104 | 39 | 3 | 10470851 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 19542352 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 22863734 | ||
| Pubmed | 2.30e-04 | 20 | 39 | 2 | 11877444 | ||
| Pubmed | PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates. | 2.54e-04 | 21 | 39 | 2 | 39304345 | |
| Pubmed | 2.54e-04 | 21 | 39 | 2 | 25707359 | ||
| Pubmed | 2.54e-04 | 21 | 39 | 2 | 28794157 | ||
| Pubmed | Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain. | 2.54e-04 | 21 | 39 | 2 | 11500373 | |
| Pubmed | Importance of EGFR/ERCC1 interaction following radiation-induced DNA damage. | 2.79e-04 | 22 | 39 | 2 | 24780295 | |
| Pubmed | Mechanical load regulates bone growth via periosteal Osteocrin. | 2.79e-04 | 22 | 39 | 2 | 34260913 | |
| Pubmed | Jagged1 is essential for osteoblast development during maxillary ossification. | 2.79e-04 | 22 | 39 | 2 | 24491691 | |
| Pubmed | 2.95e-04 | 115 | 39 | 3 | 17332742 | ||
| Pubmed | 3.05e-04 | 23 | 39 | 2 | 18297083 | ||
| Pubmed | 3.51e-04 | 122 | 39 | 3 | 29530978 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.59e-04 | 123 | 39 | 3 | 26912792 | |
| Pubmed | 3.62e-04 | 25 | 39 | 2 | 15229182 | ||
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 19590010 | ||
| Pubmed | LRP2 Acts as SHH Clearance Receptor to Protect the Retinal Margin from Mitogenic Stimuli. | 3.91e-04 | 26 | 39 | 2 | 26439398 | |
| Pubmed | Tissue-specific regulation of retinal and pituitary precursor cell proliferation. | 3.91e-04 | 26 | 39 | 2 | 12130660 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 3.91e-04 | 26 | 39 | 2 | 34189436 | |
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 26912775 | ||
| Pubmed | 4.04e-04 | 128 | 39 | 3 | 30995482 | ||
| Pubmed | 4.21e-04 | 1247 | 39 | 7 | 27684187 | ||
| Pubmed | 4.23e-04 | 27 | 39 | 2 | 33760820 | ||
| Pubmed | 4.55e-04 | 28 | 39 | 2 | 35676931 | ||
| Pubmed | Novel genes differentially expressed in cortical regions during late neurogenesis. | 4.55e-04 | 28 | 39 | 2 | 17614941 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.86e-04 | 588 | 39 | 5 | 38580884 | |
| Pubmed | 4.88e-04 | 29 | 39 | 2 | 24431450 | ||
| Pubmed | 4.88e-04 | 29 | 39 | 2 | 23652001 | ||
| Pubmed | 4.88e-04 | 29 | 39 | 2 | 25535917 | ||
| Pubmed | 4.88e-04 | 29 | 39 | 2 | 23396134 | ||
| Pubmed | Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. | 5.23e-04 | 30 | 39 | 2 | 15782174 | |
| Pubmed | 5.23e-04 | 30 | 39 | 2 | 21880902 | ||
| Pubmed | 5.23e-04 | 30 | 39 | 2 | 18055048 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 5.26e-04 | 1294 | 39 | 7 | 30804502 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.53e-04 | 605 | 39 | 5 | 28977666 | |
| Interaction | CA2 interactions | 1.12e-05 | 74 | 38 | 4 | int:CA2 | |
| Interaction | MECP2 interactions | 1.67e-05 | 1287 | 38 | 11 | int:MECP2 | |
| Interaction | YAP1 interactions | 2.52e-05 | 1095 | 38 | 10 | int:YAP1 | |
| Interaction | NUP50 interactions | 3.93e-05 | 341 | 38 | 6 | int:NUP50 | |
| Interaction | TIAM1 interactions | 3.96e-05 | 205 | 38 | 5 | int:TIAM1 | |
| Interaction | IGF2BP1 interactions | 3.98e-05 | 508 | 38 | 7 | int:IGF2BP1 | |
| Interaction | TCERG1 interactions | 4.15e-05 | 207 | 38 | 5 | int:TCERG1 | |
| Interaction | XRCC6 interactions | 4.37e-05 | 928 | 38 | 9 | int:XRCC6 | |
| Interaction | SF3B3 interactions | 7.19e-05 | 558 | 38 | 7 | int:SF3B3 | |
| Interaction | SFPQ interactions | 7.61e-05 | 563 | 38 | 7 | int:SFPQ | |
| Interaction | RBBP4 interactions | 8.49e-05 | 573 | 38 | 7 | int:RBBP4 | |
| Interaction | SUPT5H interactions | 1.06e-04 | 408 | 38 | 6 | int:SUPT5H | |
| Interaction | WWTR1 interactions | 1.27e-04 | 422 | 38 | 6 | int:WWTR1 | |
| Interaction | NUP35 interactions | 1.31e-04 | 424 | 38 | 6 | int:NUP35 | |
| Interaction | ATP5F1B interactions | 1.50e-04 | 628 | 38 | 7 | int:ATP5F1B | |
| Interaction | PRPF19 interactions | 1.81e-04 | 450 | 38 | 6 | int:PRPF19 | |
| Interaction | CAPRIN1 interactions | 1.83e-04 | 451 | 38 | 6 | int:CAPRIN1 | |
| Interaction | FUBP3 interactions | 2.26e-04 | 297 | 38 | 5 | int:FUBP3 | |
| Interaction | UBAP2L interactions | 2.30e-04 | 298 | 38 | 5 | int:UBAP2L | |
| Interaction | NUPR1 interactions | 2.51e-04 | 683 | 38 | 7 | int:NUPR1 | |
| Interaction | SF1 interactions | 2.52e-04 | 304 | 38 | 5 | int:SF1 | |
| Interaction | NANOG interactions | 2.59e-04 | 481 | 38 | 6 | int:NANOG | |
| Interaction | SNRPA interactions | 2.62e-04 | 482 | 38 | 6 | int:SNRPA | |
| Interaction | PRKDC interactions | 2.79e-04 | 695 | 38 | 7 | int:PRKDC | |
| Interaction | AMOT interactions | 2.84e-04 | 312 | 38 | 5 | int:AMOT | |
| Interaction | PABPC1 interactions | 2.89e-04 | 699 | 38 | 7 | int:PABPC1 | |
| Interaction | ENO1 interactions | 2.94e-04 | 701 | 38 | 7 | int:ENO1 | |
| Interaction | PHF5A interactions | 2.95e-04 | 171 | 38 | 4 | int:PHF5A | |
| Interaction | CHD4 interactions | 3.01e-04 | 938 | 38 | 8 | int:CHD4 | |
| Interaction | DDX6 interactions | 3.29e-04 | 503 | 38 | 6 | int:DDX6 | |
| Interaction | DDX21 interactions | 3.41e-04 | 718 | 38 | 7 | int:DDX21 | |
| Interaction | RPS20 interactions | 3.65e-04 | 513 | 38 | 6 | int:RPS20 | |
| Interaction | PSPC1 interactions | 3.73e-04 | 515 | 38 | 6 | int:PSPC1 | |
| Interaction | KCNC1 interactions | 4.09e-04 | 16 | 38 | 2 | int:KCNC1 | |
| Interaction | HDAC4 interactions | 4.22e-04 | 744 | 38 | 7 | int:HDAC4 | |
| Interaction | DIMT1 interactions | 4.31e-04 | 189 | 38 | 4 | int:DIMT1 | |
| Interaction | SF3B4 interactions | 4.33e-04 | 342 | 38 | 5 | int:SF3B4 | |
| Interaction | FMR1 interactions | 4.61e-04 | 536 | 38 | 6 | int:FMR1 | |
| Interaction | SF3B6 interactions | 4.76e-04 | 194 | 38 | 4 | int:SF3B6 | |
| Interaction | PHB2 interactions | 4.79e-04 | 540 | 38 | 6 | int:PHB2 | |
| Interaction | TARS1 interactions | 4.85e-04 | 195 | 38 | 4 | int:TARS1 | |
| Interaction | EIF3A interactions | 5.13e-04 | 355 | 38 | 5 | int:EIF3A | |
| Interaction | HIVEP3 interactions | 5.20e-04 | 18 | 38 | 2 | int:HIVEP3 | |
| Interaction | DUXB interactions | 5.20e-04 | 18 | 38 | 2 | int:DUXB | |
| Interaction | C6 interactions | 5.20e-04 | 18 | 38 | 2 | int:C6 | |
| Interaction | RALY interactions | 5.20e-04 | 356 | 38 | 5 | int:RALY | |
| Interaction | HSPD1 interactions | 5.34e-04 | 1022 | 38 | 8 | int:HSPD1 | |
| Interaction | HNRNPDL interactions | 5.75e-04 | 364 | 38 | 5 | int:HNRNPDL | |
| Cytoband | 16p11.2 | 5.80e-04 | 191 | 39 | 3 | 16p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 1.71e-03 | 278 | 39 | 3 | chr16p11 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.04e-03 | 53 | 28 | 2 | 532 | |
| GeneFamily | Ankyrin repeat domain containing | 6.06e-03 | 242 | 28 | 3 | 403 | |
| Coexpression | SENESE_HDAC1_TARGETS_UP | 4.07e-06 | 451 | 39 | 7 | M14973 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | 7.49e-06 | 495 | 39 | 7 | M8451 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 1.04e-05 | 196 | 39 | 5 | M4928 | |
| Coexpression | GSE29618_BCELL_VS_PDC_UP | 1.04e-05 | 196 | 39 | 5 | M4940 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 6.14e-05 | 467 | 39 | 6 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 7.48e-05 | 484 | 39 | 6 | MM999 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.30e-08 | 185 | 39 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.01e-08 | 199 | 39 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.04e-07 | 187 | 39 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.05e-07 | 193 | 39 | 5 | bbea475d2c4c7b29674ff302529f8f83dd666dcb | |
| ToppCell | 368C-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.23e-07 | 194 | 39 | 5 | 9a72b6a3217b100617f468aaad48566a04334f3c | |
| ToppCell | 368C-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.23e-07 | 194 | 39 | 5 | f8c46c5855a684ed5cb5289da4c29cf3e6052b97 | |
| ToppCell | severe-B_intermediate|severe / disease stage, cell group and cell class | 7.61e-07 | 196 | 39 | 5 | 8f59e51ca50bef4753f67cd1efdb02665805a120 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.00e-07 | 198 | 39 | 5 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-07 | 200 | 39 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 9.15e-06 | 151 | 39 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.15e-05 | 160 | 39 | 4 | 5744cd30709f38e84f7ec8893dc19d7a288b465a | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 174 | 39 | 4 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 174 | 39 | 4 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.79e-05 | 179 | 39 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-05 | 184 | 39 | 4 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 185 | 39 | 4 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | Control-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.08e-05 | 186 | 39 | 4 | 80f6f25dbe3c5efe4bc350f5d2eb990c38aab338 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-05 | 187 | 39 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.17e-05 | 188 | 39 | 4 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 188 | 39 | 4 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 188 | 39 | 4 | 6f53bcd4caab2fc961af799039ea5c3ddae56781 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.21e-05 | 189 | 39 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 368C-Lymphocytic-B_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 190 | 39 | 4 | b9abf773525f7bbc87b8c0d4e94e9d18017de82b | |
| ToppCell | 368C-Lymphocytic-B_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 190 | 39 | 4 | 1a016ae2603be5d024ba024faafd725787db8c48 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 190 | 39 | 4 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 190 | 39 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-05 | 190 | 39 | 4 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | remission-B_memory|World / disease stage, cell group and cell class | 2.26e-05 | 190 | 39 | 4 | c3f55f752e47b5a71e111367cdbed4a39ab5cb21 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c07-AHNAK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.30e-05 | 191 | 39 | 4 | e94dfd2d8da81bfd16f2f1a4f3ac27b078eeb3ca | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-05 | 191 | 39 | 4 | 5a9a592875fbd0b1429b48db29a760fdc9c2c856 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.30e-05 | 191 | 39 | 4 | 22134a2c1a92208bc1629a620ce73a56502613c2 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-05 | 192 | 39 | 4 | debd471f61cf3606b8e9c246add0be5df601af7f | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 2.35e-05 | 192 | 39 | 4 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_memory|COVID-19_Mild / Disease group, lineage and cell class | 2.35e-05 | 192 | 39 | 4 | d27db7669de95bddbea8ccb83e6f10ae7240b1ab | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-05 | 192 | 39 | 4 | 314f74dd3c6d94839eed05b9a1a398217ef78029 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-13|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-05 | 192 | 39 | 4 | e5ab932b4c2fed538161281ae07dfcdd82706fdd | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 193 | 39 | 4 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 2.40e-05 | 193 | 39 | 4 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 193 | 39 | 4 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.45e-05 | 194 | 39 | 4 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | COVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class | 2.45e-05 | 194 | 39 | 4 | bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.45e-05 | 194 | 39 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.50e-05 | 195 | 39 | 4 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | severe-B_intermediate|World / disease stage, cell group and cell class | 2.50e-05 | 195 | 39 | 4 | ce4bd004ceb05a269387adfed255d7fa393afcc6 | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.50e-05 | 195 | 39 | 4 | 2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0 | |
| ToppCell | severe_COVID-19-B_naive|World / disease group, cell group and cell class (v2) | 2.50e-05 | 195 | 39 | 4 | e6c77119494b787c44502c0390fb2c86a34b1846 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 2.55e-05 | 196 | 39 | 4 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 196 | 39 | 4 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-B-B_intermediate|Bac-SEP / Disease, condition lineage and cell class | 2.55e-05 | 196 | 39 | 4 | 1611920211beb1a3691e3853e0314792a74279a0 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.55e-05 | 196 | 39 | 4 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.55e-05 | 196 | 39 | 4 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.65e-05 | 198 | 39 | 4 | 8a7897d98f5296745d9005a7cd777f0a2f78000d | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.65e-05 | 198 | 39 | 4 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 2.71e-05 | 199 | 39 | 4 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | T_cells-CCR7+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.71e-05 | 199 | 39 | 4 | 467820d6abe3024d9d655b9672c2f9cdc1303db3 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class | 2.71e-05 | 199 | 39 | 4 | 1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1 | |
| ToppCell | Caecum-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 2.71e-05 | 199 | 39 | 4 | 13173cc4dcc8e856680372b0a4ad4f36afa892c1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-05 | 199 | 39 | 4 | 8e72efcd421639ac36ed036ee13f13de070d361f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | 7c495030e6566b81d97b5516d1972e335ce5ed8c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | c792d1dbbe27ebd60f4770834f30882c1a625be5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.76e-05 | 200 | 39 | 4 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.22e-04 | 153 | 39 | 3 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | (2)_NK/T-(23)_CD4+_T_cell-(230)_CD4+/CD25+_Reg_T_cell|(23)_CD4+_T_cell / immune cells in Peripheral Blood (logTPM normalization) | 3.28e-04 | 154 | 39 | 3 | 059bdf6843f94f5028d4df6aa025865a9edb4521 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 156 | 39 | 3 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 159 | 39 | 3 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-04 | 159 | 39 | 3 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.67e-04 | 160 | 39 | 3 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.81e-04 | 162 | 39 | 3 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.81e-04 | 162 | 39 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 3.81e-04 | 162 | 39 | 3 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 165 | 39 | 3 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tfh|bone_marrow / Manually curated celltypes from each tissue | 4.09e-04 | 166 | 39 | 3 | 9ac5267d3a53a96dec9eae3bc01acba4750742c8 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.09e-04 | 166 | 39 | 3 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.09e-04 | 166 | 39 | 3 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.16e-04 | 167 | 39 | 3 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.23e-04 | 168 | 39 | 3 | 07be11b6f0f37106e219692db5795c6dd32807c9 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 4.23e-04 | 168 | 39 | 3 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.38e-04 | 170 | 39 | 3 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | NS-critical-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.46e-04 | 171 | 39 | 3 | bd1ebd9037a740ad8c01c460d778b0973d8b56df | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.46e-04 | 171 | 39 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.61e-04 | 173 | 39 | 3 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | Control-CD4+_T_activated|World / Disease group and Cell class | 4.61e-04 | 173 | 39 | 3 | 12f8e4276b290bb388a56de4c8d8dd60415b2f63 | |
| ToppCell | severe-B_memory|severe / disease stage, cell group and cell class | 4.61e-04 | 173 | 39 | 3 | 3a987ac53a0136cc4c70ce8b901a15fc00c795e1 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 4.69e-04 | 174 | 39 | 3 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.69e-04 | 174 | 39 | 3 | 59ccc5a82507463e0a316ba6286cb25ec1a4091b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-04 | 175 | 39 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-04 | 175 | 39 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 4.85e-04 | 176 | 39 | 3 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.85e-04 | 176 | 39 | 3 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-04 | 177 | 39 | 3 | b326376e879afef579b1b7094d756aaff0de270b | |
| ToppCell | 3'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-04 | 177 | 39 | 3 | 393882f1bf7658a17e10a771b803339f16fb2e69 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.01e-04 | 178 | 39 | 3 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-04 | 179 | 39 | 3 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-04 | 179 | 39 | 3 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Mesenchymal-Mes|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-04 | 179 | 39 | 3 | 368f7e91e9c2c854c8778788cead022d158d1122 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.09e-04 | 179 | 39 | 3 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| Computational | Ovary genes. | 3.07e-04 | 368 | 28 | 6 | MODULE_1 | |
| Computational | DRG (dorsal root ganglia) genes. | 3.86e-04 | 384 | 28 | 6 | MODULE_2 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 8.82e-05 | 11 | 38 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | schizophrenia (implicated_via_orthology) | 9.32e-05 | 68 | 38 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 1.25e-04 | 13 | 38 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Arthritis, Psoriatic | 1.46e-04 | 14 | 38 | 2 | C0003872 | |
| Disease | Glioblastoma | 1.46e-04 | 79 | 38 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.75e-04 | 84 | 38 | 3 | C0334588 | |
| Disease | Malignant neoplasm of breast | 3.90e-04 | 1074 | 38 | 7 | C0006142 | |
| Disease | Glioblastoma Multiforme | 3.97e-04 | 111 | 38 | 3 | C1621958 | |
| Disease | Ureteral obstruction | 4.38e-04 | 24 | 38 | 2 | C0041956 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 7.82e-04 | 32 | 38 | 2 | DOID:332 (is_implicated_in) | |
| Disease | orofacial cleft | 1.05e-03 | 37 | 38 | 2 | MONDO_0000358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NGGGSLNNYSSSIPP | 251 | Q5VTM2 | |
| TPGESPGIVSNYNNS | 86 | P78363 | |
| NDGYAPPDITNSSSQ | 411 | Q12959 | |
| GSYSNSPSNPVNSRA | 136 | Q13489 | |
| SNTPGNGLASPHSQY | 91 | Q9P2D1 | |
| SGPASNGGISQTNTY | 506 | Q8IZ07 | |
| GYSNSSGCGRPQNAS | 281 | Q5D862 | |
| YPGSYSRSPAGSQQQ | 86 | Q8TAP9 | |
| SRSPAGSQQQFGYSP | 91 | Q8TAP9 | |
| GQQPAPSSTSGSYGS | 101 | P35637 | |
| YPAETLSPGGNATQS | 4091 | Q2LD37 | |
| NGSNSNPCSETYHGP | 281 | Q8WXQ8 | |
| NISGAPVTYPSAGAQ | 771 | Q86XP3 | |
| PVTYPSAGAQGVNNT | 776 | Q86XP3 | |
| SASLGNINPAYSNPS | 21 | P49281 | |
| RNTNAGAPPGTAYQS | 81 | Q02218 | |
| PSYGNPSSDVQADGA | 376 | P15391 | |
| PSPEGTTGQSYNQYS | 2431 | P02751 | |
| MSSSGYPPNQGAFST | 1 | Q9H4R4 | |
| SNYNSPGSGQNYSGP | 856 | Q12906 | |
| QGASPNAATTSGYTP | 521 | Q12955 | |
| GRSPSYLSSPQQGSQ | 336 | Q494V2 | |
| YNRAGTGPASPSANA | 891 | Q02246 | |
| PSQMNGYGSSPTFSQ | 16 | Q12929 | |
| SPGFLNGSSANSPYG | 506 | Q9H4W6 | |
| NGSSANSPYGIVPSS | 511 | Q9H4W6 | |
| PGNSPSYTERSNING | 156 | Q9NY27 | |
| PVYTSNSGTSVGPNA | 246 | Q14469 | |
| AQYGSSPQGASPASQ | 6 | P43354 | |
| YPGSSQSQSGPFQTS | 426 | Q13950 | |
| MSSSGYPPNQGAFST | 1 | O75376 | |
| PSAQTPNGTDYVASG | 1961 | Q9Y520 | |
| GSPGAQVSLYNSPSV | 76 | Q8WV41 | |
| GQFTPQSSQGTPYTS | 261 | O15047 | |
| PAQSPCYSNQSDDGS | 131 | Q9NP50 | |
| NGPSPIATASGQSEY | 101 | A0JNW5 | |
| FSIPNSSSGPYGSQD | 101 | Q8NHG8 | |
| SDPSAYQNQPGSSEA | 11 | Q9H9J4 | |
| ENHCSPGSSYQQSPG | 566 | P61129 | |
| SAPASAPSNGNCSSY | 166 | O94956 | |
| SVSQANQGNSYSPAP | 2706 | Q15413 | |
| TSSNGQNPSPGAYIL | 801 | Q9Y4F4 | |
| NYGQGSPAANSSVSP | 1166 | Q6BDS2 | |
| GSGFSNFNPNSNPSA | 296 | Q9UPQ9 | |
| PGQSSAFTSQGPGAY | 71 | O95409 |